separate if possible Proton pump inhibitors : Long-term use may reduce magnesium absorption (MHRA Drug Safety Update), potentially increasing supplementation needs Diuretics : Particularly loop and thiazide diuretics can increase urinary magnesium losses Always consult the British National Formulary (BNF) or individual medication SmPCs for specific separation timing recommendations
U.S.-licensed clinicians on every prescription, no auto-approvals
doi:10.3109/14756366.2010.526769
Even small changes in medication absorption can make a difference, she adds
SLU-PP-332 is not FDA-approved and has no human clinical trial program as of June 2026
Amylin vs GLP-1 receptor agonists GLP-1 agonists (semaglutide, liraglutide): Mechanism: GLP-1 receptor activation Primary site: Hypothalamus (arcuate nucleus) Gastric emptying: Moderate delay Weight loss: 10-15% monotherapy FDA approved: Yes (Wegovy, Saxenda) Amylin agonists (cagrilintide): Mechanism: Amylin receptor activation Primary site: Brainstem (area postrema) Gastric emptying: Strong delay (more than GLP-1) Weight loss: 10-12% monotherapy FDA approved: Not yet (Phase 3) Head-to-head comparison: Why combine GLP-1 + Amylin: Different receptor pathways Different brain sites Complementary not redundant Synergistic weight loss (15-25% combined) CagriSema proves this works See our semaglutide vs tirzepatide , semaglutide dosage calculator , and tirzepatide dosing guide
